))
Medtronic exits ventilator market; BioSig will 'substantially' cut operations
Manage episode 402156383 series 3481361
Content provided by Fast Five by MassDevice. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Fast Five by MassDevice or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, February 21, 2024. Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast. Better Therapeutics won an FDA breakthrough designation for its liver disease-treating digital therapeutic system. Fast Five hosts Danielle Kirsh and Sean Whooley talk about the therapeutic and how it earned the breakthrough nod. EnsoData won an FDA nod for its AI sleep diagnosis technology that uses pulse oximeters. Hear what sets this technology apart from other sleep apnea tracking technology. The FDA has cleared a wearable EP monitoring patch from X-trodes. Whooley explains how the technology works and what executives are saying about the future of the device. BioSig reduced its workforce for a second time in less than a month as it looks to 'substantially' cut operations. The Fast Five hosts talk about the reason behind the layoffs. Medtronic is exiting the ventilator market. Learn what the company plans to do with its existing respiratory business and how imperative ventilators were to Medtronic. BONUS: Read Danielle Kirsh's latest analysis of the medtech stock market in 2023 – How GLP-1s tanked and reshaped the medtech stock market in 2023: Analysts weigh in on how the GLP-1 craze caused one of the biggest swings in the medtech stock market in recent years.
…
continue reading
161 episodes
Share
